Fudan University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Established: 1905-01-01

Employees: 1K

Market Cap: -

Website: http://www.fudan.edu.cn

Clinical Trials

Neoadjuvant Radiation in Locally Advanced Breast Cancer

Phase 2

Recruiting

Conditions: Breast Neoplasms

Interventions: Radiation: Neoadjuvant radiotherapy

First Posted Date: 2022-07-29

Last Posted Date: 2022-07-29

Lead Sponsor: Fudan University

Target Recruit Count: 50

Registration Number: NCT05479409

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Acute and Chronic Pain After Video-assisted Thoracoscopic Surgery for Lung Cancer

Completed

Conditions: Lung Cancer

Interventions: Other: Hookwire localization

First Posted Date: 2022-07-28

Last Posted Date: 2022-10-24

Lead Sponsor: Fudan University

Target Recruit Count: 161

Registration Number: NCT05478460

Locations: 🇨🇳
270 Dongan Road, Fudan University Shanghai Cancer Center, Shanghai, China

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Phase 1

Recruiting

Conditions: Cervical Cancer

Interventions: Biological: Autologous Tumor Infiltrating Lymphocytes (C-TIL052A) Injection

First Posted Date: 2022-07-27

Last Posted Date: 2022-07-28

Lead Sponsor: Fudan University

Target Recruit Count: 20

Registration Number: NCT05475847

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, No. 270, Dong'an Road, Xuhui District, Shanghai, Shanghai, China
🇨🇳
Fudan University Shanghai Cancer Center, No. 4333, Kangxin Road, Pudong New Area, Shanghai, Shanghai, China

MammaPrint Value for Pre-menopausal Breast Cancer Patients

Active, not recruiting

Conditions: Breast Cancer

First Posted Date: 2022-07-26

Last Posted Date: 2024-02-26

Lead Sponsor: Fudan University

Target Recruit Count: 200

Registration Number: NCT05474391

Locations: 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

PD-1 Antibody Adjuvant Therapy for GC Patients With MSI-H After D2 Radical Surgery

Phase 2

Not yet recruiting

Conditions: Gastric Cancer
Adjuvant Therapy
PD-1 Immunotherapy
MSI-H

Interventions: Drug: SOX
Drug: PD-1 antibody
Other: Observation
Drug: XELOX

First Posted Date: 2022-07-21

Last Posted Date: 2022-08-26

Lead Sponsor: Fudan University

Target Recruit Count: 141

Registration Number: NCT05468138

Locations: 🇨🇳
Dazhi Xu, Shanghai, China

Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastasis

Completed

Conditions: Liver Metastases
Colorectal Cancer

Interventions: Procedure: Repeat Liver Surgery
Procedure: Non-Repeat Liver Surgery

First Posted Date: 2022-07-18

Last Posted Date: 2022-07-19

Lead Sponsor: Fudan University

Target Recruit Count: 255

Registration Number: NCT05462470

Letrozole as Maintenance Therapy for Post-surgical Endometrial Cancer Patients With NSMP

Phase 2

Recruiting

Conditions: Endometrial Cancer

Interventions: Drug: Letrozole 2.5mg

First Posted Date: 2022-07-12

Last Posted Date: 2023-09-13

Lead Sponsor: Fudan University

Target Recruit Count: 299

Registration Number: NCT05454358

Locations: 🇨🇳
Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China

Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line Chemotherapy

Phase 2

Not yet recruiting

Conditions: Colorectal Cancer Stage IV
Colorectal Cancer

Interventions: Drug: Capecitabine
Drug: Fruquintinib Plus Capecitabine

First Posted Date: 2022-07-11

Last Posted Date: 2022-07-12

Lead Sponsor: Fudan University

Target Recruit Count: 116

Registration Number: NCT05451719

Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer

Recruiting

Conditions: Ovarian Cancer

Interventions: Other: ND-EOC or platinum-sensitive rEOC

First Posted Date: 2022-07-06

Last Posted Date: 2023-12-28

Lead Sponsor: Fudan University

Target Recruit Count: 139

Registration Number: NCT05446545

Locations: 🇨🇳
Hao Wen, Shanghai, Shanghai, China

Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)

Recruiting

Conditions: Esophageal Cancer

First Posted Date: 2022-07-05

Last Posted Date: 2023-07-13

Lead Sponsor: Fudan University

Target Recruit Count: 385

Registration Number: NCT05443841

Locations: 🇨🇳
The Fourth Hospital of Hebei Medical University, Shijia Zhuang, Hebei, China
🇨🇳
The First Affiliated Hospital of USTC, Hefei, Anhui, China
🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China

and more 8 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy